1. Home
  2. IBRX vs VC Comparison

IBRX vs VC Comparison

Compare IBRX & VC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IBRX
  • VC
  • Stock Information
  • Founded
  • IBRX 2014
  • VC 2000
  • Country
  • IBRX United States
  • VC United States
  • Employees
  • IBRX N/A
  • VC N/A
  • Industry
  • IBRX Biotechnology: Biological Products (No Diagnostic Substances)
  • VC Auto Parts:O.E.M.
  • Sector
  • IBRX Health Care
  • VC Consumer Discretionary
  • Exchange
  • IBRX Nasdaq
  • VC Nasdaq
  • Market Cap
  • IBRX 2.4B
  • VC 2.0B
  • IPO Year
  • IBRX N/A
  • VC 2000
  • Fundamental
  • Price
  • IBRX $2.06
  • VC $84.92
  • Analyst Decision
  • IBRX Strong Buy
  • VC Buy
  • Analyst Count
  • IBRX 5
  • VC 13
  • Target Price
  • IBRX $11.35
  • VC $101.25
  • AVG Volume (30 Days)
  • IBRX 8.8M
  • VC 384.1K
  • Earning Date
  • IBRX 05-16-2025
  • VC 04-24-2025
  • Dividend Yield
  • IBRX N/A
  • VC N/A
  • EPS Growth
  • IBRX N/A
  • VC N/A
  • EPS
  • IBRX N/A
  • VC 10.69
  • Revenue
  • IBRX $14,745,000.00
  • VC $3,867,000,000.00
  • Revenue This Year
  • IBRX $579.28
  • VC N/A
  • Revenue Next Year
  • IBRX $179.96
  • VC $3.80
  • P/E Ratio
  • IBRX N/A
  • VC $7.82
  • Revenue Growth
  • IBRX 2270.58
  • VC N/A
  • 52 Week Low
  • IBRX $1.83
  • VC $65.10
  • 52 Week High
  • IBRX $9.16
  • VC $117.94
  • Technical
  • Relative Strength Index (RSI)
  • IBRX 36.89
  • VC 67.67
  • Support Level
  • IBRX $1.83
  • VC $77.19
  • Resistance Level
  • IBRX $2.17
  • VC $81.60
  • Average True Range (ATR)
  • IBRX 0.18
  • VC 2.49
  • MACD
  • IBRX -0.05
  • VC 1.06
  • Stochastic Oscillator
  • IBRX 23.56
  • VC 98.58

About IBRX ImmunityBio Inc.

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.

About VC Visteon Corporation

Visteon Corp is an automotive supplier. It manufactures electronics products for original equipment vehicle manufacturers including Ford, Nissan, Renault, Mazda, BMW, General Motors, and Honda, etc. The company offers information displays, instrument clusters, head-up displays, infotainment systems, telematics solutions, and Smartcore. The Company's reportable segment is Electronics. The Electronics segment provides vehicle cockpit electronics products to customers, including digital instrument clusters, domain controllers with integrated driver assistance systems, displays, Android-based infotainment systems, and battery management systems. Geographically, it operates in North America, Europe, China, Asia-Pacific, and South America and Others.

Share on Social Networks: